Breast cancer
INACTIVE --- Adjuvant systemic treatment of luminal A/B early breast cancerCharlotta (43 years old)
Charlotta is a 43-year-old tour guide in Stockholm and loves to show the hidden charms of Sweden’s capital to tourists. Recently, she was diagnosed with early breast cancer following a screening mammography.
Assessment summary
- No relevant medical history or family history of cancer
- Premenopausal, regular menstrual cycles. Nulliparous (G0P0)
- Stage and tumour biology (core biopsy) at diagnosis:
- cT2N0M0
- G2, invasive carcinoma of no special type, ER 100%, PgR 90%, HER2 negative (IHC 0), Ki67 25%
- Breast conserving surgery with oncoplastic techniques + SLNB
- Pathology report:
- G2 bifocal invasive carcinoma, 20 mm largest foci
- Intermediate grade DCIS 15%
- Lymphovascular invasion present. No perineural invasion.
- R0 resection (free margins)
- 1 involved sentinel lymph node (1/4 sn)
- pT1c(m)N1a(sn) cM0
- Multidisciplinary board meeting
- Gene expression profiling: luminal B intrinsic subtype, high risk of recurrence (MammaPrint Index: -0.115; average 10-year risk of recurrence if untreated: 29%)
- Adjuvant chemotherapy, followed by RT and endocrine therapy